Pharmaceuticals
Inovio Receives Authorization from the U.S. FDA To Begin Phase 1/2 Clinical Trial for INO-3107, a DNA Medicine To Treat a Rare Disease -- Recurrent Respiratory Papillomatosis (RRP)
- RRP is a rare, potentially fatal orphan disease caused by Human Papillomavirus (HPV) 6 and 11 - Inovio's DNA medicine pipeline includes 15 clinical programs focused on HPV-associated diseases, cancer, and infectious diseases, including the novel coronavirus (2019-nCoV) PLYMOUTH MEETING, Penns...
2020-02-10 19:00
2872
GenScript ProBio Screens anti-2019 nCoV Antibodies in Just 24 Hours
NANJING, China, Feb. 10, 2020 /PRNewswire/ -- On February 4, 4:46 a.m., escorted by public security officers, 8 transgenic mice for fully human antibodies immunized with antigen from 2019 nCoV from Rongchang District, Chongqing were brought by Chongqing Academy of Animal Sciences and Chongqing CA...
2020-02-10 10:49
2016
RhoVac Announces Appointment of Professor Anne J. Ridley to its Scientific Advisory Board
STOCKHOLM, Feb. 6, 2020 /PRNewswire/ -- RhoVac AB ("RhoVac") announces today, 6 th February 2020, the appointment of a leading oncology expert to its Scientific Advisory Board with the addition ofAnne J. Ridley, PhD, Professor of Cell Biology and Head of School of Cellular and Molecular Medicine, ...
2020-02-06 20:22
1480
Breakthrough Study Makes Cancer Detection Possible With a Simple Blood Test; Introduces a New Systemic Hallmark of Cancer
MUMBAI, India, Feb. 6, 2020 /PRNewswire/ -- A new study
2020-02-06 08:00
2465
Christian Kinch Resigns as CEO of Bactiguard and is Proposed as New Chairman of the Board. Cecilia Edström Appointed New CEO
STOCKHOLM, Sweden, Feb. 5, 2020 /PRNewswire/ -- Christian Kinch today announced to the Board that he will resign as CEO of Bactiguard Holding AB (publ) after close to 16 years. The Board has appointed CFO and Deputy CEOCecilia Edström as new CEO of Bactiguard andStefan Grass (CMO) as Deputy CEO. ...
2020-02-05 06:38
11313
Pharmacy Alliance members come together in support of bushfire affected pharmacies & communities
SYDNEY, Feb. 4, 2020 /PRNewswire/ -- Pharmacy Alliance has established a
bushfire appeal, aiming to raise$250,000 to support bushfire affected
pharmacies in providing free medication and personal care items to their
communities.
2020-02-04 08:15
1887
Trefoil Therapeutics Selects AGC Biologics as Lead Manufacturer of TTHX1114 for Treatment of Corneal Diseases
SEATTLE, Feb. 4, 2020 /PRNewswire/ -- AGC Biologics, a global Contract Development and Manufacturing Organization (CDMO) for Biopharmaceuticals and Trefoil Therapeutics announce the execution of a manufacturing contract to supply their lead compound TTHX1114. Trefoil is developing products based...
2020-02-04 06:00
1952
Inovio Publishes Patient Benefit Results From A Pilot Clinical Study in Recurrent Respiratory Papillomatosis (RRP), A Rare Disease Caused by HPV Infections
PLYMOUTH MEETING, Pennsylvania, Feb. 3, 2020 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced publication of data from its pilot clinical study of INO-3106, a novel DNA therapy targeting human papilloma virus type 6 (HPV 6) for the treatment of recurrent respiratory pap...
2020-02-03 21:00
2535
Demand for CROs Rises to Strike Evolving Clinical Trial Models for Target Therapies
Increased acceptance of outsourcing clinical trials predicted to propel sector revenues to$71.7 billion by 2024 SANTA CLARA, Calif., Feb. 3, 2020 /PRNewswire/ -- With an overall R&D expenditure of$167 billion in 2018, the global healthcare industry is investing heavily in the development of nove...
2020-02-03 17:01
1532
GSK announces European Medicines Agency (EMA) accepted marketing authorisation application for belantamab mafodotin for the treatment of relapsed or refractory multiple myeloma
- Belantamab mafodotin accepted for accelerated assessment by the EMA's Committee for Human Medicinal Products (CHMP) - Submission based on data from the pivotal DREAMM-2 study of immunoconjugate targeting B-cell maturation antigen (BCMA) recently published inThe Lancet Oncology LONDON, Feb. 3,...
2020-02-03 17:00
9278
The Antimicrobial Crisis: New Antibiotics Could Avert 230,000 Deaths Per Year
Recent clinical studies presented at International Symposium organized by Fondazione Internazionale Menarini The World Health Organization warns: invest more and invest now in research to avoid catastrophic consequences for public health FLORENCE, Italy, Jan. 30, 2020 /PRNewswire/ -- The introdu...
2020-01-30 23:09
2537
Inovio Collaborating With Beijing Advaccine To Advance INO-4800 Vaccine Against New Coronavirus In China
Agreement will facilitate clinical trial translations in China PLYMOUTH MEETING, Pa., Jan. 30, 2020 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced that it is collaborating with Beijing Advaccine Biotechnology Co. to advance the development inChina of INO-4800, Inovio'...
2020-01-30 19:00
4461
Infinitus donates 6 million yuan in cash and supplies to support prevention and treatment efforts in dealing with 2019-nCoV
GUANGZHOU, China, Jan. 29, 2020 /PRNewswire/ -- In the last few days, all attention inChina is focused on the prevention and treatment of the pneumonia caused by the novel coronavirus (2019-nCoV). Medical staff from both Wuhan and around the country, as well as people from all walks of life, are ...
2020-01-29 21:04
2255
XJTLU Researcher Adding Piece To Puzzle Of New Coronavirus
SUZHOU, JIANGSU, China, Jan. 29, 2020 /PRNewswire/ -- According to a researcher at Xi'an Jiaotong-Liverpool University, the Wuhan coronavirus, nCoV-2019, is closely related to SARS from the viewpoint of virus evolution. "Our findings suggest the nCoV-2019 lineage is related to the bat coronavir...
2020-01-29 12:06
2236
WuXi Biologics Enables Development of Multiple Neutralizing Antibodies for Novel Coronavirus
SHANGHAI, Jan. 29, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, has stepped up its efforts in enabling the development of multipl...
2020-01-29 10:00
3392
Systech Deploys First Serialization Lines for Takeda Pharmaceutical International AG to Meet New Russian Regulations
PRINCETON, New Jersey, Jan. 28, 2020 /PRNewswire/ -- Systech, the global technology leader in brand protection and digital product authentication, announced today it has successfully upgraded serialization lines forTakeda to meet new Russian serialization regulations.October 1, 2019 was the first...
2020-01-28 01:19
2575
Week's Top Stories
Most Reposted
Supported by the Luxembourg Government, The Luxembourg House of Financial Technology (LHoFT) and the Asian Development Bank (ADB) Announce the 2nd Edition of Catapult | SE Asia 2025
[Picked up by 313 media titles]
2025-01-22 15:38
dss⁺ Announces Strategic Changes to Executive Leadership Team in Asia Pacific Accelerating growth and impact for high-hazard industries in the region
[Picked up by 309 media titles]
2025-01-21 16:00
HARD ROCK HOTEL BALI ACHIEVES PRESTIGIOUS GSTC CERTIFICATION
[Picked up by 306 media titles]
2025-01-20 14:27
Blackpanda Recognized with Frost & Sullivan's Asia Pacific Company of the Year Award for Incident Response Excellence
[Picked up by 298 media titles]
2025-01-23 09:00
Infobip Research Unveils Opportunities for Brands to Engage Customers with Rich Communication Services (RCS) across APAC
[Picked up by 291 media titles]
2025-01-20 21:09
Most Read
dss⁺ Announces Strategic Changes to Executive Leadership Team in Asia Pacific Accelerating growth and impact for high-hazard industries in the region
2025-01-21 16:00
5981
HARD ROCK HOTEL BALI ACHIEVES PRESTIGIOUS GSTC CERTIFICATION
2025-01-20 14:27
4903
Premium Features, Budget Price: Don't Miss the Fossibot S3 Pro's Dual-Screen AMOLED Debut
2025-01-19 15:00
4382
TikTok "Refugees" Flock to U.S. Owned Rival, Triller
2025-01-19 03:53
4050
Be My Guest: The Embroidery Episode
2025-01-19 21:23
4013